¼¼°èÀÇ ÀÚ°¡¼¼Æ÷ Ä¡·á ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2032³â)
Global Autologous Cell Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
»óǰÄÚµå : 1578296
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 128 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,671,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,843,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,750,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀÚ°¡¼¼Æ÷ Ä¡·á ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 48¾ï 6,000¸¸ ´Þ·¯¿¡¼­ 2032³â 307¾ï 1,000¸¸ ´Þ·¯¿¡ À°¹ÚÇÏ´Â ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, 2024-2032³âÀÇ Á¶»ç ±â°£ µ¿¾È 22.74%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

ÀÚ°¡¼¼Æ÷ Ä¡·á(ACT)´Â °³ÀÎÀÇ ¼¼Æ÷¸¦ ÀÌ¿ëÇØ ´Ù¾çÇÑ Áúº´À» Ä¡·áÇÏ´Â »õ·Î¿î Ä¡·á¹ýÀÔ´Ï´Ù. ȯÀÚÀÇ ¼¼Æ÷¸¦ ü¿Ü¿¡¼­ ¹è¾çÇϰí ü¿Ü¿¡¼­ ¼¼Æ÷ ¼ö¸¦ ´Ã·Á ´Ù½Ã ü³»·Î µÇµ¹·Á ³Ö´Â´Ù. ÀÌ Ä¡·á¹ýÀº ºÎÀÛ¿ë, »ýüÀûÇÕ¼º, À̽Ŀ¡ µû¸¥ Áúº´ Àü¿°, Àü½Å ¸é¿ª ¹ÝÀÀ ¹× Áúº´ À§Çè °¨¼Ò¸¦ º¸ÀåÇÕ´Ï´Ù. ÀÌ Ä¡·á¹ý¿¡´Â ÀÚ°¡ Áٱ⼼Æ÷ Ä¡·á¿Í ÀÚ°¡¼¼Æ÷ ¸é¿ª Ä¡·áÀÇ µÎ °¡Áö À¯ÇüÀÌ ÀÖ½À´Ï´Ù. ÀÚ°¡ Áٱ⼼Æ÷ Ä¡·á´Â °ñ¼ö Ç¥Çdzª ´Ù¸¥ °ø±Þ¿ø¿¡¼­ äÃëÇÑ ¼¼Æ÷¸¦ ¹è¾çÇϰí Áõ½Ä½Ãŵ´Ï´Ù. ÀÚ°¡ Áٱ⼼Æ÷ Ä¡·á´Â ¾Ï, ±Ù°ñ°Ý°è Áúȯ, Ç÷¾× Áúȯ, ¹Ì¿ë Ä¡·á µî¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. º´¿ø°ú ¿¬±¸¼Ò´Â ȯÀÚ Ä¡·á¸¦ À§ÇØ ÀÚ°¡ Áٱ⼼Æ÷ Ä¡·á¹ýÀ» Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¾Ï, ½Å°æÁúȯ, ÀÚ°¡¸é¿ªÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ÀÚ°¡Ä¡·áÁ¦ ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ºÎÀÛ¿ë °¨¼Ò¿Í ´Ù¸¥ Áúº´À¸·ÎÀÇ ÀüÀÌ À§Çè °¨¼Ò¿Í °°Àº ¿äÀεéÀÌ ½ÃÀåÀ» Ȱ¼ºÈ­½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¼Æ÷¹è¾ç R&D Áõ°¡¿Í »õ·Î¿î Çõ½ÅÀû Ä¡·á¹ý¿¡ ´ëÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºêÀÌ ¼¼°è ½ÃÀåÀ» °ßÀÎÇϰí ÀÖÀ¸¸ç, Äڷγª19ÀÇ ¼¼°èÀû ´ëÀ¯Çà ±â°£ µ¿¾È ÀÚ°¡¼¼Æ÷Ä¡·áÁ¦ ½ÃÀåÀº ¼¼Æ÷¹è¾ç Ä¡·áÀÇ R&D Áõ°¡¿Í ÇÔ²² Àüü ÇコÄÉ¾î ½ÃÀåÀÇ ¼ºÀåÀ¸·Î ÀÎÇØ ¾ÈÁ¤ÀûÀ̱ä ÇÏÁö¸¸ ¿Ï¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ÀÚ°¡¼¼Æ÷ Ä¡·á ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÚ°¡¼¼Æ÷ Ä¡·á »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

¸ÂÃãÇü ¿ä±¸»çÇ×ÀÌ ÀÖ´Â °æ¿ì, ÀúÈñ¿¡°Ô ¿¬¶ôÁֽñ⠹ٶø´Ï´Ù. ´ç»çÀÇ Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Àڱ⼼Æ÷ Ä¡·á - »ê¾÷ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ Àڱ⼼Æ÷ Ä¡·á ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦6Àå ¼¼°èÀÇ Àڱ⼼Æ÷ Ä¡·á ½ÃÀå ºÐ¼® : °ø±Þ¿øº°

Á¦7Àå ¼¼°èÀÇ Àڱ⼼Æ÷ Ä¡·á ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ Àڱ⼼Æ÷ Ä¡·á ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå Àڱ⼼Æ÷ Ä¡·á ±â¾÷ÀÇ °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global demand for Autologous Cell Therapy Market is presumed to reach the market size of nearly USD 30.71 Billion by 2032 from USD 4.86 Billion in 2023 with a CAGR of 22.74% under the study period 2024-2032.

Autologous cell therapy (ACT) is a novel therapy that uses an individual's cells to treat various diseases. The therapy utilizes the patient's cells, which are cultured outside the body, the cell number is expanded in-vitro and reintroduced to the body. The therapy assures reduced side effects, reduced the risk of bio-incompatibility, disease transmission associated with graft, and systemic immunological reactions and disease. The therapy can be of two types; autologous stem cell therapy and autologous cellular immune therapies. The cells from bone marrow epidermis or other sources are utilized for cell culture and expansion. Autologous therapy is applied in the treatment of cancers, musculoskeletal disorders, blood disorders, and cosmetic treatments. Hospitals and research centers are increasing the use of autologous therapy to treat patients.

MARKET DYNAMICS

The growing prevalence of cancer, neurological disorders, and autoimmune diseases are the prime factors that are driving the autologous therapy market. The factors such as reduced side effects and reduced risk of transmission of other diseases are fuelling the market. Moreover, increasing R & D in cell culture, and government initiatives in novel innovative therapies is uplifting the global market. During the global pandemic COVID-19, the autologous therapy market is expected to experience steady but inclining growth owing to the growing overall healthcare market along with rising R & D in cell culture therapies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Autologous Cell Therapy. The growth and trends of Autologous Cell Therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Autologous Cell Therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

By Source

By End-use

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Autologous Cell Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autologous Cell Therapy market include BrainStorm Cell Therapeutics, Holostem Terapie Avanzate, S.R.L, Pharmicell Co. Inc, Opexa Therapeutics, Caladrius Biosciences Inc, U.S. Stem Cell Inc, Lonza, Bristol Myers Squibb, Novartis, Autolus Therapeutics, Tego Science, Corning Incorporated, Bio Elpida, Vericel Corporation, Catalent Inc, Sartorius AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. AUTOLOGOUS CELL THERAPY - INDUSTRY ANALYSIS

4. VALUE CHAIN ANALYSIS

5. GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY APPLICATION

6. GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY SOURCE

7. GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY END-USE

8. GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY GEOGRAPHY

9. COMPETITIVE LANDSCAPE OF THE AUTOLOGOUS CELL THERAPY COMPANIES

10. COMPANY PROFILES OF AUTOLOGOUS CELL THERAPY INDUSTRY

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â